Showing results (171-180 of 192) with videos related to
Sort By:
Pageof 20
Growth Factors (Chur, Switzerland)|January 1, 1997
Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptorA M Dougher, H Wasserstrom, L Torley, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 27, 2018
Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance TherapyAndrew J Cowan, Philip A Stevenson, Edward N Libby, et al.Head & Neck|November 22, 2022
Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostatCassie Pan, Qian Vicky Wu, Jenna Voutsinas, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 11, 2026
Biomarkers Informed by Single-Cell and Spatial Transcriptomics - Biomarkers for Grade 3 Follicular LymphomaAarti Kanzaria, Sonali Arora, Anisha Naik, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland CancerCristina P Rodriguez, Qian Vicky Wu, Jenna Voutsinas, et al.Cancer Medicine|February 22, 2023
Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitorsCassie Pan, Qian Vicky Wu, Jenna Voutsinas, et al.Practical Radiation Oncology|October 5, 2019
Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell LymphomaAileen Kim, Philip Stevenson, Ryan D Cassaday, et al.Journal of Human Immunity|May 6, 2026
X-linked SEPTIN6-related congenital neutropenia and B cell deficiencyLauren M Gunderman, Aleksandra Petrovic, Ingrid Lundgren, et al.British Journal of Haematology|February 8, 2020
Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapyStephen D Smith, Brian G Till, Mazyar S Shadman, et al.Clinical Lymphoma, Myeloma & Leukemia|November 5, 2023
Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-UpCarrie Ho, Ajay K Gopal, Brian G Till, et al.Pageof 20